Drug intelligence / Profile preview

amezinium metilsulfate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Amezinium metilsulfate is a sympathomimetic small molecule drug primarily used for the treatment of hypotensive states, including essential and orthostatic hypotension. It acts by stimulating alpha and beta-1 adrenergic receptors, inhibiting monoamine oxidase (MAO), and blocking neuronal uptake of noradrenaline and tyramine. These combined actions increase blood pressure by enhancing sympathetic tone and reducing norepinephrine breakdown or reuptake. The drug is administered orally, with typical side effects including palpitations, headache, nausea/vomiting, hot flashes, and hypertension[2][5][7][8].

Brand names
RegultonSupratonin
Other names
amezinium methylsulfateamezinium methyl sulfateamezinium metisulfate4-amino-6-methoxy-1-phenylpyridazinium methylsulfate
02

Targets

ADRA1A (α1A)MAOA (Monoamine oxidase A)ADRB1 (β1)

Beyond the preview

Go deeper on amezinium metilsulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amezinium metilsulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call